FDA schedules circulatory devices session:
This article was originally published in Clinica
The FDA will hold a meeting of its circulatory system devices advisory panel on September 21 in Gaithersburg, Maryland, to discuss clinical trial design in the evaluation of cardiopulmonary resuscitation devices and therapies. The meeting comes at a time when the American College of Cardiology is in the midst of rethinking its CPR guidelines for first responders. Recent research suggests that emergency medical personnel should conduct CPR first before using an automatic external defibrillator to treat a patient in cardiac arrest.